XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Revenues:    
Total revenues $ 10,032,641 $ 10,758,191
Expenses:    
Cost of product revenues 8,541,574 6,624,101
Research and development 2,100,753 2,312,217
Selling, general and administration 7,231,865 4,648,130
Litigation damages 24,800,000
Total expenses 42,674,192 13,584,448
Loss from operations (32,641,551) (2,826,257)
Other income:    
Interest income 172,840 101,765
Other (expense) income, net (43) 37,030
Foreign currency transaction (losses) gains (79,461) 97,907
Total other income 93,336 236,702
Loss before provision for income taxes (32,548,215) (2,589,555)
Tax provision (39,000)
Net loss $ (32,548,215) $ (2,628,555)
Net loss per share    
Basic $ (0.27) $ (0.03)
Diluted $ (0.27) $ (0.03)
Weighted average number of common shares outstanding    
Basic 120,114,985 105,036,382
Diluted 120,114,985 105,036,382
Net Product Revenues [Member]    
Revenues:    
Total revenues $ 9,025,366 $ 7,654,716
Research and Development Revenues [Member]    
Revenues:    
Total revenues 899,965 2,896,451
Other Revenues [Member]    
Revenues:    
Total revenues $ 107,310 $ 207,024